169261 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing; Immunoassay; Biospecific binding assay; Materials therefor for cancer; Specifically defined cancers of colon
CANCER BIOMARKER AND METHODS OF USING THEREOF
#602Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
#603METHOD FOR PREDICTING THE THERAPEUTIC RESPONSEIVENESS OF A PATIENT TO A MEDICAL TREATMENT WITH AN EGFR INHIBITOR
#604Method for determining sensitivity to irinotecan and use thereof
#605Prodefensin-A6 assay method for the in vitro diagnosis of colorectal cancer
#606ANTIBODIES AS A CANCER DIAGNOSTIC
#607Granules with reduced dust potential comprising an antifoam agent
#608Cancer Diagnostics
#609METHODS FOR THE DIAGNOSIS OR PROGNOSIS OF COLORECTAL CANCER
#610BIOMARKERS AND METHODS FOR DETERMINING EFFICACY OF ANTI-EGFR ANTIBODIES IN CANCER THERAPY
#611FCgamma POLYMORPHISMS FOR PREDICTING DISEASE AND TREATMENT OUTCOME
#612Materials and methods for determining cancer risk
#613PROTEIN-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF COLORECTAL ADENOCARCINOMA
#614Prostate cancer diagnosis and treatment
#615Use of a growth-stimulating protein
#616Serpentine transmembrane antigens expressed in human cancers and uses thereof
#617YKL-40 as a marker for gastrointestinal cancers
#618Use of myeloid cell biomarkers for the diagnosis of cancer
#619Compounds and methods useful for detection and treatment of cancer
#620PTA089 PROTEIN
#621Anti-trop-2 monoclonal antibodies and uses thereof in the treatment and diagnosis of tumors
#622TUMOR MARKERS AND METHODS OF USE THEREOF
#623Treatment devices and methods with extending elements
#624Skin treatment devices and methods with pre-stressed configurations
#625Gene Expression Markers for Prediction of Response to Platinum-Based Chemotherapy Drugs
#626PHOSPHOSPECIFIC PAK ANTIBODIES AND DIAGNOSTIC KITS
#627Tumor markers and methods of use thereof
#628Gene expression markers for prediction of patient response to chemotherapy
#629YKL-40 AS A MARKER FOR SELECTION OF TREATMENT AND MONITORING OF A DISEASE
#630METHODS OF CLASSIFYING THE SEVERITY OF DISEASES OR DISORDERS
#631RBM3 in Testicular Cancer Diagnostics and Prognostics
#632Markers for cancer detection
#633RBM3 in colorectal cancer prognostics
#634Use of protein SATB2 as a marker for colorectal cancer
#635ANTI-HEDGEHOG ANTIBODIES
#636COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFLAMMATORY BOWEL DISEASE AND COLON CANCER
#637Diagnosis or prognosis of lung cancer and colorectal cancer based on expression level of glutaredoxin 3
#638METHODS FOR PREDICTING CANCER RESPONSE TO EGFR INHIBITORS
#639Molecular-based method of cancer diagnosis and prognosis
#640Methods and compositions for diagnosis and treatment of cancer
#641Multiplex Detection of Tumour Cells Using a Panel of Agents Binding to Extracellular Markers
#642Method for Detecting Metastasis of GI Cancer
#643COLON CANCER TARGETS AND USES THEREOF
#644TISSUE INHIBITOR OF MATRIX METALLOPROTEINASES TYPE-1 (TIMP-1) AS A CANCER MARKER AND POSTOPERATIVE MARKER FOR MINIMAL RESIDUAL DISEASE OR RECURRENT DISEASE IN PATIENTS WITH A PRIOR HISTORY OF CANCER
#645Anti-cancer drug screening method using RORα
#646Method for Using Gene Expression to Determine Colorectal Tumor Stage
#647THERAPEUTIC AND DIAGNOSTIC METHODS RELATING TO CANCER STEM CELLS
#648CIRCULATING Epha2 RECEPTOR
#649COLON DISEASE TARGETS AND USES THEREOF
#650USE OF S-ERBB-3 AS A MARKER FOR CANCER
#651Clinical Method for Individualized Epithelial Cancer Screening Involving ERCC5 and IGF2R Genetic Testing and Gene-Environment Interactions
#652METHODS FOR IDENTIFYING GENES WHICH PREDICT DISEASE OUTCOME FOR PATIENTS WITH COLON CANCER
#653Methods for Detecting Tumor Origin Based on MUC1, MUC2, and CK-17 Expression Levels
#654Methods and Systems for Diagnosis of Non-Central Nervous System (CNS) Diseases in CNS Samples
#655Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin
#656INDIVIDUAL 5-FLUOROURACILE DOSE OPTIMIZATION IN FOLFOX TREATMENT
#657USING PHAGE EPITOPES TO PROFILE THE IMMUNE RESPONSE
#658Methods and systems of using exosomes for determining phenotypes
#659METHODS AND MATERIALS FOR DETECTING COLORECTAL NEOPLASM
#660BIDESMOSIDIC BETULIN AND BETULINIC ACID DERIVATIVES AND USES THEREOF AS ANTITUMOR AGENTS
#661Epitopes derived from SATB2 and uses thereof
#662Methods and compositions for detecting colon cancers
#663TREATMENT OF METASTATIC COLON CANCER WITH B-SUBUNIT OF SHIGA TOXIN
#664Biomarkers Indicative of Colon Cancer and Metastasis and Diagnosis and Screening Therapeutics Using the Same
#665SIGNAL PATHWAY ALTERATIONS AND DRUG TARGET ELEVATIONS IN PRIMARY METACHRONOUS METASTATIC COLORECTAL CANCER COMPARED TO NON-METASTATIC DISEASE
#666Methods and compositions for identifying inhibitors of MutSα or MutSβ interaction with MutLα
#667Antibody drug conjugate treatment of colorectal cancer
#668INFLAMMATORY GENES AND MICRORNA-21 AS BIOMARKERS FOR COLON CANCER PROGNOSIS
#669Detecting neoplasm
#670Methods to identify responsive patients
#671Methods for treating colorectal cancer
#672GFATS As Modifiers of the AXIN Pathway and Methods of Use
#673SELECTION OF COLORECTAL CANCER PATIENTS FOR NEO-ADJUVANT AND ADJUVENT SYSTEMIC ANTI-CANCER TREATMENT
#674Aberrant methylation of C6Orf150 DNA sequences in human colorectal cancer
#675Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof
#676USE OF RUNX3 AND MIR-532-5P AS CANCER MARKERS AND THERAPEUTIC TARGETS
#677USE OF RUNX3 AND MIR-532-5P AS CANCER MARKERS AND THERAPEUTIC TARGETS
#678Methods and systems of using exosomes for determining phenotypes
#679EPHRIN-B RECEPTOR PROTEIN INVOLVED IN CARCINOMA
#680SOLUBLE CADHERIN 17 FOR THE DIAGNOSIS AND RISK STRATIFICATION OF CANCER AND TUMOR OF THE GASTROINTESTINAL TRACT
#681CALPROTECTIN AND HEMOGLOBIN/HAPTOGLOBIN COMPLEX FROM STOOL SAMPLE TO ASSESS COLORECTAL CANCER
#682Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
#683Methods and Compositions for Treating Carcinoma Stem Cells
#684Monoclonal antibodies to progastrin and their uses
#685COLON STEM CELLS ASSOCIATED WITH COLITISAND COLORECTAL CANCER AND METHODS OF USE
#686Gene expression markers for colorectal cancer prognosis
#687Protein
#688Protein disulfide isomerase assay method for the in vitro diagnosis of colorectal cancer
#689Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
#690Gene expression markers for colorectal cancer prognosis
#691Gene Prognosis Predictor Signature for Colorectal Carcinoma
#692Immunoassays to detect diseases or disease susceptibility traits
#693Proliferation Signatures and Prognosis for Gastrointestinal Cancer
#694COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN
#695Methods for making cancer prognoses based on subcellular localization of biomarkers
#696Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
#697Prostate cancer diagnosis and treatment
#698TISSUE INHIBITOR OF MATRIX METALLOPROTEINASES TYPE-1 (TIMP-1) AS A CANCER MARKER
#699COMBINATION THERAPY
#700Biomarker Panel For Prediction Of Recurrent Colorectal Cancer
#701P13K pathway mutations in cancer
#702Polynucleotides encoding signal peptide-containing molecules
#703Methods for determining cancer resistance to histone deacetylase inhibitors
#704METHYLATION DETECTION IN THE GENOMIC REGION OF A RECEPTOR PROTEINTYROSINE PHOSPHATASE GAMMA GENE FOR DETECTION AND/OR DIAGNOSIS OF A TUMOUR
#705Tumor-targeting monoclonal antibodies to FZD10 and uses thereof
#706Gene expression markers for colorectal cancer prognosis
#707Gene expression markers for colorectal cancer prognosis
#708Gene expression markers for colorectal cancer prognosis
#709Gene expression markers for colorectal cancer prognosis
#710NOVEL FER -LIKE PROTEIN, PHARMACEUTICAL COMPOSITIONS CONTAINING IT AND METHOD FOR ITS USE
#711Methods Involving MS4A12 and Agents Targeting MS4A12 for Therapy, Diagnosis and Testing
#712PTTG1 as a biomarker for cancer treatment
#713Pharmaceutical composition for inhibiting peritoneal dissemination
#714Biomarker combinations for colorectal cancer
#715Marks as modifiers of the p53 pathway and methods of use
#716Method of detecting colon cancer marker
#717Carcinoma diagnosis and treatment, based on ODC1 genotype
#718BIOMARKERS FOR IGF-1R INHIBITOR THERAPY
#719Use of FZC18-Containing Collagen 18 Polypeptides for the Treatment, Diagnosis and Outcome Prediction of Diseases
#720Identification of cancer protein biomarkers using proteomic techniques
#721Molecular profiling of tumors
#722Method of assessing colorectal cancer status in an individual
#723METHODS AND TOOLS FOR DISCRIMINATING COLORECTAL ADENOMAS AND ADENOCARCINOMAS
#724METHODS FOR DETERMINING A PROGNOSIS OF COLORECTAL CANCER
#725Humanised antibodies with anti-tumour activity
#726METHOD OF DETECTING THE RISK OF CANCER USING GENETIC MARKERS
#727METHOD FOR DIAGNOSING SELECTED ADENOCARCINOMAS
#728SOCS-3 promoter methylation in cancer
#729Aldehyde dehydrogenase 1 (ALDH1) as a cancer stem cell marker
#730Genes and polypeptides relating to hepatocellular or colorectal carcinoma
#731Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy
#73215-PGDH in colon cancer
#733PROTEIN
#734HADHs as Modifiers of the p21 Pathway and Methods of Use
#735Use of an endoplasmin fragment and derivatives thereof as biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
#736Methods of diagnosing cancer
#737Determination of 5-ASA efficacy in CRC prevention and/or treatment by gene expression analysis
#738MARKERS FOR DIAGNOSIS OF CANCER AND ITS USE
#739Cancer diagnostic kit and cancer diagnostic method
#740IN VITRO METHOD FOR DIAGNOSING TUMOR DISEASES
#741Compositions and methods for the treatment and prevention of ulcerative colitis and colon cancer and screening methods to identify same
#742Method for providing diagnosis of cancer using seprase as a marker
#743MARKER PANEL FOR COLORECTAL CANCER
#744Method for early detection of cancers
#745USE OF RUNX3 AND MIR-532-5P AS CANCER MARKERS AND THERAPEUTIC TARGETS
#746Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators
#747Method for detecting cancer and reagents for use therein
#748CANCER MARKERS
#749Methods and compositions for detecting colon cancers
#750Methods and systems of using exosomes for determining phenotypes
#751Organ Homing Genes of Cancer Metastases
#752Gene expression markers for colorectal cancer prognosis
#753Reagents And Methods For Cancer Prognosis And Pathological Staging
#754Methods of identifying agents that modulate methylation of VEGFR1 by SMYD3
#755Method of Predicting Non-Response to First Line Chemotherapy
#756Methods and systems of using exosomes for determining phenotypes
#757Tat-005 and Methods of Assessing and Treating Cancer
#758Methods for Detecting Nucleic Acids Indicative of Cancer
#759METHODS AND COMPOSITIONS FOR TREATING DISEASES TARGETING MABA1
#760Laminin receptor 1 precursor protein (37LRP) epitope delineated by an hepatocellular carcinoma specific antibody
#761TIMP-1 AS A MARKER FOR COLORECTAL CANCER
#762SCDs as modifiers of the p53 pathway and methods of use
#763Assays and methods using biomarkers
#764FXDY5 MODULATORS FOR TREATING, DIAGNOSING, AND DETECTING CANCER
#765Method for the assay of liver fatty acid binding protein, ACE and CA 19-9 for the in vitro diagnosis of colorectal cancer
#766PRO115 antibody compositions and methods of use
#76726199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor
#768BIOMARKERS FOR COLORECTAL CANCER
#769METHOD OF ASSAYING APOLIPOPROTEIN AI FOR THE IN VITRO DIAGNOSIS OF COLORECTAL CANCER
#770I-Plastin assay method for the in vitro diagnosis of colorectal cancer
#771Ezrin assay method for the in vitro diagnosis of colorectal cancer
#772Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer
#773ANTIBODIES RECOGNIZING OXYGEN-REGULATED PROTEIN 150 EXPRESSED ON CANCER CELLS AND METHODS OF USING SAME
#774Apolipoprotein AII assay method for the in vitro diagnosis of colorectal cancer
#775Aminoacylase 1 assay method for the in vitro diagnosis of colorectal cancer
#776Method of assaying leukocyte elastase inhibitor for the in vitro diagnosis of colorectal cancer
#777Immunotherapeutic method
#778Methods and compositions for modulating angiogenesis
#779Targeted delivery to legumain-expressing cells
#780Methods For Detecting Colorectal Diseases And Disorders
#781IL-4 RECEPTOR AND IL-13 AS PROGNOSTIC MARKERS FOR COLON AND PANCREAS TUMORS
#782Suppression of cancer and method for evaluating anticancer agent based on the effect of inhibiting gsk3 beta
#783Method and apparatus for determining a probability of colorectal cancer in a subject
#784PROTEINS
#785PROTEINS
#786Protein
#787USE AND IDENTIFICATION OF BIOMARKERS FOR GASTROINTESTINAL DISEASES
#788PROTEIN KINASE C IOTA
#789Perinucleolar compartment as a cancer marker
#790Method for detecting and controlling cancer
#791IDENTIFICATION OF PROTEIN BIOMARKERS ASSOCIATED WITH LYMPH NODE METASTASIS IN COLORECTAL CANCER
#792Use of N-myristoyltransferase on non-tumor tissue for cancer diagnosis
#793Methods for Identifying Compounds that Modulate WNT Signaling in Cancer Cells
#794Methods and kits for early detection of cancer or predisposition thereto
#795Methods for Identifying Cancer Risk
#796Methods and compounds for lymphoma cell detection and isolation
#797METHOD FOR THE DETECTION OF INTERFERON-ASSOCIATED ANGIOSTATIC TUMORSTAGES IN COLORECTAL CARCINOMA
#798COMPOSITIONS AND METHODS FOR DETECTING CANCERS IN A SUBJECT
#799Metastasis specific splice variants of mena and uses thereof in diagnosis, prognosis and treatment of tumors
#800DRUG FOR DIAGNOSING LARGE INTESTINAL CANCER AND/OR POLYP, OBSERVING POSTOPERATIVE COURSE AND MONITORING RECURRENCE
#801Nucleic acids encoding IL-17 homologous receptor-like polypeptides and therapeutic uses thereof
#802GENETIC VARIATIONS ASSOCIATED WITH TUMORS
#803Digestive system cancer stem cells and tests and uses therefor
#804Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use
#805Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use
#806METHOD FOR EXAMINING COLORECTAL CANCER AND COLORECTAL ADENOMA
#807COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN
#808Diagnostic and therapeutic methods
#809Method, apparatus, system, program, and computer-readable recording medium for evaluating colorectal cancer
#810Methods and compositions for detecting colon cancers
#811ASSAY FOR METASTATIC COLORECTAL CANCER
#812Anti-hedgehog antibodies
#813NUCLEAR MATRIX PROTEIN ALTERATIONS ASSOCIATED WITH COLON CANCER AND THEIR USE AS MARKERS FOR COLORECTAL CANCER
#814Antibodies to PRO352
#815IL-17 homologous polypeptides and therapeutic uses thereof
#816METHODS AND NUCLEIC ACIDS FOR THE DETECTION OF COLORECTAL CELL PROLIFERATIVE DISORDERS
#817Methods and compositions for categorizing patients
#818Gene expression markers for prediction of patient response to chemotherapy
#819Method of detecting colon cancer marker
#820METHODS FOR DETECTING NUCLEIC ACIDS INDICATIVE OF CANCER
#821Gene expression markers for colorectal cancer prognosis
#822USE OF PROTEIN S100A12 AS A MARKER FOR COLORECTAL CANCER
#823Methods for Identifying Compounds that Affect Expression of Cancer-Related Protein Isoforms
#824Methods and Compositions for the Prediction of Response to Trastuzumab Containing Chemotherapy Regimen in Malignant Neoplasia
#825Novel Tumour Suppressor
#826Diagnostic tests and personalized treatment regimes for cancer stem cells
#827Diagnostic markers predictive of outcomes in colorectal cancer treatment and progression and methods of use thereof
#828Method for establishing the sensitivity of tumours to capecitabin and test kit
#829Gene expression markers for prediction of patient response to chemotherapy
#830Method of determining the sensitivity of cancer cells to EGFR inhibitors including cetuximab, panitumumab and erlotinib
#831Methods for Diagnosing and Treating Kidney and Colorectal Cancer
#832PROTEIN ASSOCIATED WITH COLORECTAL CANCER, POLYNUCLEOTIDE INCLUDING SINGLE-NUCLEOTIDE POLYMORPHISM ASSOCIATED WITH COLORECTAL CANCER, MICROARRAY AND DIAGNOSTIC KIT INCLUDING THE SAME, AND METHOD OF DIAGNOSING COLORECTAL CANCER USING THE SAME
#833Novel Tannase Gene And Protein Thereof
#834PROTEIN
#835PROTEIN
#836UHRF1 DIRECTED DIAGNOSTICS FOR NEOPLASTIC DISEASE
#837TTK DIRECTED DIAGNOSTICS FOR NEOPLASTIC DISEASE
#838Use Of A Growth-Stimulating Protein
#839Four-jointed box (FJX1) in cancer diagnosis and treatment
#840Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
#841NUCLEIC ACIDS ENCODING RECEPTOR FOR IL-17 HOMOLOGOUS POLYPEPTIDES AND USES THEREOF
#842NUCLEAR MATRIX PROTEIN ALTERATIONS ASSOCIATED WITH COLON CANCER AND COLON METASTASIS TO THE LIVER, AND USES THEREOF
#843Methods to detect tumors using 20P1F12/TMPRSS2 expression
#844Diagnosis and prognosis of colorectal cancer
#845Use of protein SATB2 as a marker for colorectal cancer
#846Methods for prognosing the recurrence of gastrointestinal and other cancers using the Shc proteins
#847Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
#848Phosphospecific PAK antibodies and diagnostic kits
#849Novel nucleotide and amino acid sequences, and assays methods of use thereof for diagnosis of colon cancer
#850Colon cancer related gene TOM34
#851Cytotoxicity mediation of cells evidencing surface expression of CD44
#852Secreted protein called 36P6D5 characteristic of tumors
#853Method of treating colorectal carcinoma
#854TUMOR MARKER AND METHOD FOR DETERMINATION OF THE OCCURRENCE OF CANCEROUS DISEASE
#855Methods for treating colorectal cancer using prognostic genetic markers
#856FCgamma POLYMORPHISMS FOR PREDICTING DISEASE AND TREATMENT OUTCOME
#857Intact IGFBP-3 as a Colon Cancer Risk Factor in Patients With Inflammatory Bowel Disease
#858Methods for detecting colon carcinoma
#859PROTEINS
#860Methods for the treatment or prevention of scars and/or keloids
#861Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
#862PROGNOSTIC ASSAY FOR METACHRONOUS COLORECTAL CANCER
#863ASC as a marker for colorectal cancer
#864Human Ron-related gene variant associated with cancers
#865Human Ron-related gene variant associated with cancers
#866JAB1 as a prognostic marker and a therapeutic target for human cancer
#867Methods for diagnosis and treatment of epithelial-derived cancers
#868Identification of biomarkers by serum protein profiling
#869Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase 1 (sgk1)
#870METHOD OF DIAGNOSING COLON AND GASTRIC CANCERS
#871METHODS FOR DETERMINING THE PROGNOSIS FOR CANCER PATIENTS USING TUCAN
#872Methods for determining cancer resistance to histone deacetylase inhibitors
#873DRUG SCREENING AND MOLECULAR DIAGNOSTIC TEST FOR EARLY DETECTION OF COLORECTAL CANCER: REAGENTS, METHODS, AND KITS THEREOF
#874ASSESSING COLORECTAL CANCER BY MEASURING OSTEOPONTIN AND CARCINOEMBRYONIC ANTIGEN
#875ASSESSING COLORECTAL CANCER BY MEASURING HEMOGLOBIN AND M2-PK IN A STOOL SAMPLE
#876Cancer antigen and use thereof
#877Methods and compositions for detecting colon cancers
#878PRO1190 polypeptides
#879METHOD FOR DETECTING, SCREENING, AND/OR MONITORING CANCER IN AN INDIVIDUAL
#880Methods of detecting methyl transferase activity and methods of screening for methyl transferase activity modulators
#881Methods and compositions for treating diseases targeting MABA1
#882MARKERS FOR DIAGNOSIS OF CANCER AND ITS USE
#883Collagen VI and cancer
#884Human Mob-5 (IL-24) receptors and uses thereof
#885Cancer Screening Test
#886Methods and Materials for Examining the P13k/Akt Pathway in Gliomas and Prostate Cancers
#887Method for the analysis of differential expression in colorectal cancer
#888Methods of and kits and compositions for diagnosing colorectal tumors
#889Method of Diagnosing, Monitoring, Staging, Imaging and Treating Colon Cancer
#890PIK4CA as modifier of the Rac pathway and methods of use
#891TISSUE INHIBITOR OF MATRIX METALLOPROTEINASES TYPE-1 (TIMP-1) AS A CANCER MARKER AND POSTOPERATIVE MARKER FOR MINIMAL RESIDUAL DISEASE OR RECURRENT DISEASE IN PATIENTS WITH A PRIOR HISTORY OF CANCER
#892Methods for the Diagnosis of Colorectal Cancer and Ovarian Cancer by the Measurement of Vitamin E-Related Metabolites
#893Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
#894Antibodies Against Histone Modifications for Clinical Diagnosis and Prognosis of Cancer
#895SPHKS as modifiers of the p53 pathway and methods of use
#896COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN
#897Method for inducing immune response to NY-CO-58
#898Cytotoxicity mediation of cells evidencing surface expression of CD44
#899GENES AND POLYPEPTIDES RELATING TO HEPATOCELLULAR OR COLORECTAL CARCINOMA
#900Method For Diagnosing Colorectal Cancers